Digital Health – The new standard
Asthma and COPD affect over 500 million people worldwide. Learn more from Sven Dethlefs, EVP Global Marketing & Portfolio and International Markets, as he discusses how Teva is trying to address respiratory diseases through digital health solutions.
Digital Health – The new standard
Asthma and COPD affect over 500 million people worldwide. Learn more from Sven Dethlefs, EVP Global Marketing & Portfolio and International Markets, as he discusses how Teva is trying to address respiratory diseases through digital health solutions.
Find out more
- Learn how Xinyu Liu develops Teva’s digital products and devices to help both patients and healthcare professionals.
- Read stories of patients with asthma.
- Understand more about Teva's specialty therapeutic areas.
At Teva, we strive to deliver quality medicines to patients around the world with integrity and ethical business practices. What we do is important, but how we do it is just as important. Learn more:
Copyright © 2024 Teva Pharmaceutical Industries Ltd.